Dertlioğlu Selma B, Çalık Mustafa, Çiçek Demet
Department of Dermatology, Fırat University, Elazığ, Turkey.
Int J Dermatol. 2014 Apr;53(4):516-23. doi: 10.1111/ijd.12254. Epub 2013 Dec 10.
Lipoid proteinosis (LP) is a rare autosomal recessive genodermatosis characterized by mucocutaneous lesions and hoarseness that develop in early childhood. This paper presents the clinical and radiologic characteristics and treatment responses of 10 LP patients from five different families.
Ten LP patients followed in our university clinic in Şanlıurfa, Turkey, were evaluated. Clinical features, as well as histopathologic and radiologic findings, were analyzed. Diagnoses were established based on clinical features, with histopathologic confirmation in nine cases. The patients were started on acitretin at a dose of 0.5 mg/kg/day for six months.
Typical cutaneous signs of LP and hoarseness of the voice were observed in all patients. No side effects associated with the drug were found during treatment. At the end of the sixth month, the cutaneous papules and plaques were diminished in seven patients. Hoarseness receded in seven patients (particularly in three), vesiculobullous lesions were reduced in three patients, and the frequency of oral ulcers decreased in three patients. In a patient with palmoplantar hyperkeratosis, lesions were found to disappear completely.
We believe acitretin is quite effective and reliable in the treatment of cutaneous lesions and hoarseness in patients with LP.
类脂蛋白沉积症(LP)是一种罕见的常染色体隐性遗传性皮肤病,其特征为在儿童早期出现皮肤黏膜病变和声音嘶哑。本文介绍了来自五个不同家庭的10例LP患者的临床和放射学特征以及治疗反应。
对在土耳其尚勒乌尔法我们大学诊所随访的10例LP患者进行了评估。分析了临床特征以及组织病理学和放射学检查结果。根据临床特征进行诊断,9例经组织病理学确诊。患者开始服用阿维A,剂量为0.5毫克/千克/天,持续6个月。
所有患者均观察到LP典型的皮肤体征和声音嘶哑。治疗期间未发现与药物相关的副作用。在第六个月末,7例患者的皮肤丘疹和斑块减少。7例患者(尤其是3例)声音嘶哑减轻,3例患者的水疱大疱性病变减少,3例患者口腔溃疡的频率降低。1例掌跖角化过度患者的病变完全消失。
我们认为阿维A在治疗LP患者的皮肤病变和声音嘶哑方面非常有效且可靠。